Auro Laboratories Complete Financial Statements

In FY2025, Auro Laboratories (AUROLAB) reported revenue ₹10 Cr, net profit ₹1 Cr and EPS ₹1.15, with a net profit margin of 10.0% and ROE of 2.3%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see AUROLAB share price.

11 Years of Data
2025 - 2015

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 10.00% 2025 data
EBITDA Margin 30.00% 2025 data
Operating Margin 27.00% 2025 data
Return on Assets 1.01% 2025 data
Return on Equity 2.33% 2025 data

Balance Sheet Ratios

Current Ratio 0.63 2025 data
Equity Ratio 43.43% 2025 data
Asset Turnover 0.10 2025 data

AUROLAB Revenue, Net Profit & EBITDA — Year-on-Year Growth

AUROLAB YoY (Sept 2024 vs Sept 2025) — revenue +233.3%, EBITDA +200.0%, expenses +250.0%.

Revenue Growth
+233.3%
Year-over-Year
EBITDA Growth
+200.0%
Year-over-Year
Expense Growth
+250.0%
Year-over-Year
Assets Growth
+15.1%
Year-over-Year
Equity Growth
+2.4%
Year-over-Year
Operating Cash Flow Growth
-68.4%
Year-over-Year
Investing Cash Flow Growth
+35.9%
Year-over-Year
Financing Cash Flow Growth
-5.3%
Year-over-Year

AUROLAB Income Statement — Revenue, EBITDA & Net Profit

Auro Laboratories revenue ₹10 Cr, EBITDA ₹3 Cr, net profit ₹1 Cr, EPS ₹1.15 (2025) — net profit margin 10.0%. Explore AUROLAB true value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2025 Jun 2025 Sept 2024 Jun 2024
Revenue 10 3 3 6
Expenses 7 3 2 4
EBITDA 3 0 1 2
Operating Profit Margin % 27.00% 1.00% 23.00% 23.00%
Depreciation 1 0 0 0
Interest 1 0 0 0
Profit Before Tax 2 0 1 1
Tax 1 0 0 0
Net Profit 1 0 0 1
Earnings Per Share (₹) 1.15 -0.17 0.57 1.21

AUROLAB Balance Sheet — Assets, Liabilities & Shareholders' Equity

AUROLAB total assets ₹99 Cr, total equity ₹43 Cr, total liabilities ₹ Cr (2025) — ROE 2.3%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 99 86 56 55 42 32 34 30 27 26 29
Current Assets 22 31 36 38 28 18 19 16 14 12 18
Fixed Assets 21 22 13 14 14 14 15 13 13 9 10
Capital Work in Progress 57 33 8 4 0 0 0 1 0 3 1
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 22 31 36 38 28 18 19 16 14 13 18
LIABILITIES
Total Liabilities
Current Liabilities 35 20 4 3 4 5 10 11 11 7 8
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 43 42 34 32 29 22 17 13 9 9 8
Share Capital 6 6 6 6 6 6 6 6 6 6 6
Reserves & Surplus 37 36 28 25 22 15 11 7 3 2 2

AUROLAB Cash Flow Statement — Operating, Investing & Financing

Auro Laboratories operating cash flow ₹6 Cr, investing ₹-25 Cr, financing ₹18 Cr, net cash flow ₹-1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 6 19 3 -7 13 9 7 6 7 8 -1
Investing Activities -25 -39 -5 -5 -4 -2 -3 -3 -2 -2 -1
Financing Activities 18 19 -8 10 -1 -6 -2 -2 -4 -5 1
Net Cash Flow -1 -1 -10 -2 9 2 2 1 1 0 -1